1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Pipeline Insights, 2016


DelveInsight’s, “ End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). DelveInsight’s Report also assesses the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Pipeline Insights, 2016

Illustrative Table of contents

- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Overview
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Pipeline Therapeutics
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics under Development by Companies
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Filed and Phase III Products
- Comparative Analysis
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Phase II Products
- Comparative Analysis
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Phase I and IND Filed Products
- Comparative Analysis
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Discontinued Products
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Dormant Products
- Companies Involved in Therapeutics Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Monotherapy Products
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Combination Products
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Route of Administration
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Stage and Route of Administration
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Molecule Type
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Stage and Molecule Type
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics - Discontinued Products
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Monotherapy Products
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Combination Products
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Route of Administration
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Stage and Route of Administration
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Molecule Type
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Polycystic kidney disease (PKD)- Market Insights, Epidemiology and Market Forecast-2023

Polycystic kidney disease (PKD)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Polycystic kidney disease (PKD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Polycystic kidney disease (PKD) - Epidemiology Forecast To 2023

Polycystic kidney disease (PKD) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Polycystic kidney disease (PKD) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Polycystic kidney disease (PKD) in seven major markets (US, France, ...

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by Global Data

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials ...


Download Unlimited Documents from Trusted Public Sources

Type 2 Diabetes Statistics in the UK

  • November 2016
    27 pages
  • Diabetes  

    Type 2 Diabetes  

    Surgery  

  • United Kingdom  

    United States  

    World  

View report >

Therapy Market and Stroke Statistics in the US

  • November 2016
    11 pages
  • Therapy  

    Cardiovascular ...  

    Stroke  

  • United States  

View report >

Diabetes Statistics in Finland

  • November 2016
    6 pages
  • Diabetes  

  • Finland  

View report >

Related Market Segments :

Renal Disease

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.